[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100646502":3},{"organization":4,"armGroups":7,"interventions":22,"overallOfficials":30,"centralContacts":10,"locations":34,"responsibleParty":54,"collaborators":56,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":65,"acronym":10,"eligibilityCriteria":66,"healthyVolunteers":67,"sex":68,"minAge":69,"maxAge":10,"enrollmentInfo":70,"targetDuration":10,"studyType":73,"phases":10,"briefSummary":74,"conditions":75,"keywords":10,"overallStatus":77,"whyStopped":10,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":82,"completionDateStruct":84,"leadSponsor":86,"locationsCount":87},{"fullName":5,"class":6},"City of Hope Medical Center","OTHER",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Observational Aim I",null,"Average and high risk breast cancer participants and early onset breast cancer patients complete a survey over 15-25 minutes and may attend an interview over 30-45 minutes. Participants' and patients' medical records are reviewed.",[13],"Other: Non-Interventional Study",{"label":15,"type":10,"description":16,"interventionNames":17},"Observational Aim II","COH providers complete a survey over 15-25 minutes and may attend an interview over 30-45 minutes.",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"Observational Aim III","Average and high risk breast cancer participants complete a baseline survey over 15-25 minutes and wear Fresh Air Clip wristbands for 1 week. Participants then complete a follow up survey over 15-25 minutes and may attend an interview over 30-45 minutes. Participants' medical records are reviewed.",[13],[23],{"type":6,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"Non-Interventional Study","Non-interventional study",[9,15,19],[28,29],"Non-Interventional Observational Study","Noninterventional (Observational) Study",[31],{"name":32,"affiliation":5,"role":33},"Stacy W Gray","PRINCIPAL_INVESTIGATOR",[35],{"facility":5,"status":10,"city":36,"state":37,"zip":38,"country":39,"countryCode":40,"cosmosGeoPoint":41,"geoPoint":46,"contacts":47},"Duarte","California","91010","United States","US",{"type":42,"coordinates":43},"Point",[44,45],-117.97729,34.13945,{"lat":45,"lon":44},[48,53],{"name":49,"role":50,"phone":51,"phoneExt":10,"email":52},"Stacy W. Gray","CONTACT","626-218-4768","stagray@coh.org",{"name":49,"role":33,"phone":10,"phoneExt":10,"email":10},{"type":55,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR",[57],{"name":58,"class":59},"National Cancer Institute (NCI)","NIH","100646502","environmental-exposure-assessment-in-high-risk-and-early-onset-breast-cancer-care-100646502",false,"NCT07690852","Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care","Precision Prevention: Environmental Exposure Assessment in High-Risk and Early-Onset Breast Cancer Care","Inclusion Criteria:\n\n* AIM 1 INCLUSION CRITERIA:\n\n  * ONE of the following:\n\n    * Either average risk of developing breast cancer (defined by woman with no Tyrer-Cuzick model ≥ 20%, no mention of Tyrer-Cuzick model, and no Pathogenic\u002FLikely Pathogenic \\[P\u002FLP\\] in breast cancer related genes) OR high risk of developing breast cancer (defined by ≥ 20% chance of developing breast cancer across lifetime measured by Tyrer-Cuzick model or gene mutation carrier, P\u002FLP carrier in breast cancer related genes including BRCA1, BRCA2, BARD1, ATM, CHEK2, CDH1, NF1, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53) OR early onset breast cancer (defined by a breast cancer diagnosis in a patient younger than 50 years of age)\n  * Age: ≥ 18 years\n  * Speak English or Spanish\n  * Sex: female\n  * Willingness to:\n\n    * Participate in study activities\n    * Permit medical record\u002F clinical laboratory result review\n* AIM 2 INCLUSION CRITERIA\n\n  * Practice at COH (i.e., genetic counselors, geneticists, oncologists, nurse practitioners)\n  * Willingness to:\n\n    * Participate in study activities\n* AIM 3 INCLUSION CRITERIA:\n\n  * Provide written consent\n  * ONE of the following:\n\n    * Either average risk of developing breast cancer (defined by woman with no Tyrer-Cuzick model ≥ 20%, no mention of Tyrer-Cuzick model, and no P\u002FLP in breast cancer related genes) OR High risk: empirical risk of developing breast cancer (defined by ≥ 20% chance of developing breast cancer across lifetime measured by Tyrer-Cuzick model and no P\u002FLP in breast cancer related genes) OR High Risk: gene carrier (defined by P\u002FLP carrier in breast cancer related genes, including BRCA1, BRCA2, BARD1, ATM, CHEK2, CDH1, NF1, PALB2, PTEN, RAD51C, RAD51D, STK11, TP53)\n  * Age: ≥ 18 years\n  * Speak English or Spanish\n  * Sex: female\n  * Willingness to:\n\n    * Wear the wristband for 1 week\n    * Participate in study activities\n    * Permit medical record\u002F clinical laboratory result review",true,"FEMALE","18 Years",{"count":71,"type":72},423,"ESTIMATED","OBSERVATIONAL","This study evaluates patient and provider attitudes about environmental exposure risk assessments into clinical care for female patients at average or high risk for breast cancer and\u002For diagnosed with early onset breast cancer.",[76],"Breast Carcinoma","NOT_YET_RECRUITING","2026-07-06",{"date":80,"type":81},"2026-07-08","ACTUAL",{"date":83,"type":72},"2026-12-28",{"date":85,"type":72},"2028-01-01",{"name":5,"class":6},1]